C200-5541 Screening compound: 2-(3-chloro-4-ethoxyphenyl)-5-({5-methyl-2-[4-(propan-2-yloxy)phenyl]-1,3-oxazol-4-yl}methyl)-4H,5H-pyrazolo[1,5-a]pyrazin-4-one

C200-5541 Screening compound: 2-(3-chloro-4-ethoxyphenyl)-5-({5-methyl-2-[4-(propan-2-yloxy)phenyl]-1,3-oxazol-4-yl}methyl)-4H,5H-pyrazolo[1,5-a]pyrazin-4-one
C200-5541 Screening compound: 2-(3-chloro-4-ethoxyphenyl)-5-({5-methyl-2-[4-(propan-2-yloxy)phenyl]-1,3-oxazol-4-yl}methyl)-4H,5H-pyrazolo[1,5-a]pyrazin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound C200-5541
2-(3-chloro-4-ethoxyphenyl)-5-({5-methyl-2-[4-(propan-2-yloxy)phenyl]-1,3-oxazol-4-yl}methyl)-4H,5H-pyrazolo[1,5-a]pyrazin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C200-5541

Molecular Formula

C28H27ClN4O4 (C28 H27 ClN4 O4)

Compound Name

2-(3-chloro-4-ethoxyphenyl)-5-({5-methyl-2-[4-(propan-2-yloxy)phenyl]-1,3-oxazol-4-yl}methyl)-4H,5H-pyrazolo[1,5-a]pyrazin-4-one

IUPAC name

2-(3-chloro-4-ethoxyphenyl)-5-({5-methyl-2-[4-(propan-2-yloxy)phenyl]-13-oxazol-4-yl}methyl)-4H5H-pyrazolo[15-a]pyrazin-4-one

SMILES

CCOc(ccc(-c1nn(C=CN(Cc2c(C)oc(-c(cc3)ccc3OC(C)C)n2)C2=O)c2c1)c1)c1Cl

InChI

InChI=1S/C28H27ClN4O4/c1-5-35-26-11-8-20(14-22(26)29)23-15-25-28(34)32(12-13-33(25)31-23)16-24-18(4)37-27(30-24)19-6-9-21(10-7-19)36-17(2)3/h6-15,17H,5,16H2,1-4H3

InChI Key

GIQRBAHIUWXROO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD26961615

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

519

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.680

Distribution Coefficient, logD

4.680

Water Solubility, LogSw

-4.92

Polar Surface Area

60.106

Acid Dissociation Constant (pKa)

28.56

Base Dissociation Constant (pKb)

-2.01

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

C200-5541 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

Human Receptors Annotated Library (5376 compounds)

Immunological Library (6760 compounds)

Therapeutical Diversity Annotated Library (7563 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Immune system

References: we are preparing a list of scientific research reports with C200-5541 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C200-5541?
Check Price and Availability of C200-5541, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C200-5541 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C200-5541
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C200-5541
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C200-5541 available by request